Clinical research in Asia opportunities and challenges
Asia is increasingly taking on a leading role in the fields of Good Clinical Practice (GCP) and ethics, two areas that are central to clinical research practices worldwide. Clinical research in Asia examines the evolution of these key sectors in the Asian countries where the greatest developments ar...
| Autor principal: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Philadelphia, Pa. :
Woodhead Pub
2012.
|
| Colección: | Woodhead Publishing series in biomedicine ;
no. 10 Woodhead Publishing Series in Biomedicine |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009634674606719 |
Tabla de Contenidos:
- Cover; Dedication; Clinical research in Asia: Opportunities and challenges; Copyright; Contents; List of figures and tables; Acknowledgments; List of abbreviations; Preface; About the author; 1 Clinical research in Asia: a brief overview; 1.1 Background; 1.2 Global pharmaceutical market; 1.3 Clinical research business - a global overview; 1.4 CRO services mix; 1.5 The clinical research boom in Asia; 1.6 Asian country segmentation analysis; 1.7 Clinical trials in Asia; 1.8 Inspection and data quality; 1.9 Clinical research in Asia - SWOT analysis; 2 Clinical research in Japan
- 2.1 Background and history2.2 Clinical research industry in Japan; 2.3 The regulatory environment in Japan; 2.4 Evolution of Japanese good clinical practice; 2.5 Global clinical trials in Japan; 2.6 Emerging outsourcing models in Japan; 2.7 Japan's international strategic outlook; 2.8 Future outlook; 3 Clinical research in India; 3.1 Pharmaceutical industry background; 3.2 History of clinical research in India; 3.3 Evolution of clinical research in India; 3.4 Regulatory environment in India; 3.5 Clinical trial approval; 3.6 Difference between ICH-GCP and Indian GCP
- 3.7 Regulatory inspections in India3.8 Clinical research in India: PESTLE analysis; 3.9 Future outlook; 4 Clinical research in China; 4.1 Pharmaceutical market; 4.2 Pharmaceutical investments in China; 4.3 China's healthcare system; 4.4 Healthcare delivery system; 4.5 The importance of traditional medicine in modern healthcare; 4.6 China's CRO market; 4.7 Clinical trials in China; 4.8 Accreditation of clinical trial sites in China; 4.9 Clinical research in China - environmental analysis; 4.10 Future outlook; 5 Clinical research in South Korea; 5.1 Pharmaceutical industry overview
- 5.2 CRO market in South Korea5.3 Clinical trial environment; 5.4 Evolution of GCP in South Korea; 5.5 Clinical trials in South Korea; 5.6 Accreditation of medical centres; 5.7 Environmental analysis; 5.8 Future outlook; 6 Clinical research in Taiwan; 6.1 Pharmaceutical industry overview; 6.2 Biotech industry in Taiwan; 6.3 Healthcare system in Taiwan; 6.4 CRO market in Taiwan; 6.5 Evolution of GCP in Taiwan; 6.6 Clinical trials in Taiwan; 6.7 Future outlook; 7 Clinical research in Singapore; 7.1 Overview of the pharmaceutical industry in Singapore; 7.2 Pharmaceutical investments in Singapore
- 7.3 Governing authority and regulatory structure7.4 Healthcare system in Singapore; 7.5 Clinical research in Singapore; 7.6 CRO market; 7.7 Clinical trials in Singapore; 7.8 Evolution of GCP in Singapore; 7.9 Role of clinical trial resource centre; 7.10 Environmental analysis; 7.11 Clinical trial challenges; 7.12 Future outlook; 8 Clinical research in Thailand; 8.1 Pharmaceutical industry in Thailand; 8.2 The pharmaceutical regulatory environment; 8.3 Pharmaceutical market; 8.4 Clinical research in Thailand; 8.5 CRO market in Thailand; 8.6 Hospital systems in Thailand
- 8.7 Conducting clinical trials in Thailand
